US Map / Missouri
State MO

Clinical Trials in Missouri

Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.

Total Trials
296
Recruiting Now
296
← Back to US Map
Top Conditions in Missouri
Multiple Myeloma (8)Advanced Solid Tumor (7)Breast Cancer (7)Obesity (5)Colorectal Cancer (5)Prostate Cancer (5)Asthma (4)Stage IVB Prostate Cancer AJCC v8 (4)Acute Ischemic Stroke (3)Advanced Solid Tumors (3)Neuroblastoma (3)Chronic Lymphocytic Leukemia (3)

Frequently Asked Questions — Clinical Trials in Missouri

How many clinical trials are currently recruiting in Missouri?
ClinicalMetric currently tracks 296 actively recruiting clinical trials with at least one location in Missouri. The total number of registered studies—including active but not currently enrolling trials—is 296. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Missouri?
Missouri hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Advanced Solid Tumor, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Missouri serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Missouri?
To join a clinical trial in Missouri, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Missouri maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Missouri

NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06514794 Phase 2
Recruiting
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-C...
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
125 pts
Location
United States, Australia
Sponsor
Wugen, Inc.
View Trial →
NCT07020273 N/A
Recruiting
CONNECT Cancer Survivors With Tobacco Treatment
Condition
Tobacco Use
Enrollment
5,000 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT04899947 N/A
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Condition
Narcolepsy
Enrollment
500 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT06476132 Phase 2
Recruiting
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung...
Condition
Lung Transplant
Enrollment
234 pts
Location
United States, Canada
Sponsor
National Institute of Allergy
View Trial →
NCT02915198 Phase 4
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuT...
Condition
Prediabetic State
Enrollment
7,410 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT05201781 Phase 4
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autole...
Condition
Multiple Myeloma
Enrollment
295 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
View Trial →
NCT05718063 N/A
Recruiting
MAP for Coaches: Translating Sports Injury Prevention Knowledge to Youth Sport C...
Condition
Knowledge, Attitudes, Practice
Enrollment
200 pts
Location
United States
Sponsor
St. Louis University
View Trial →
NCT04457206 N/A
Recruiting
Effectiveness of the Collaborative Community Clinic for Persons With Spinal Cord...
Condition
Spinal Cord Injuries
Enrollment
200 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT06516952 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant...
Condition
Prurigo Nodularis
Enrollment
330 pts
Location
United States, Argentina, Austria
Sponsor
Incyte Corporation
View Trial →
NCT07115940 N/A
Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alon...
Condition
Acute Ischemic Stroke
Enrollment
408 pts
Location
United States
Sponsor
Amrou Sarraj
View Trial →
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT06433115 N/A
Recruiting
Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome
Condition
Diet Intervention
Enrollment
90 pts
Location
United States
Sponsor
University of Missouri-Columbi
View Trial →
NCT04177914 Phase 3
Recruiting
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Condition
Hydrocephalus
Enrollment
176 pts
Location
United States, Canada
Sponsor
University of Utah
View Trial →
NCT06896916 Phase 1
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cerebl...
Condition
Multiple Myeloma
Enrollment
135 pts
Location
United States, Australia, Canada
Sponsor
AbbVie
View Trial →
NCT07404852 N/A
Recruiting
Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blo...
Condition
Large Vessel Occlusion
Enrollment
65 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT07204340 Phase 1
Recruiting
TLN-372 in Advanced KRAS Mutant Solid Tumors
Condition
KRAS Mutant Solid Tumors
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
Treeline Biosciences, Inc.
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05219617 Phase 3
Recruiting
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizu...
Condition
Seizures
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
SK Life Science, Inc.
View Trial →
NCT04557618 N/A
Recruiting
Auricular VNS Following Subarachnoid Hemorrhage
Condition
Subarachnoid Hemorrhage
Enrollment
50 pts
Location
United States
Sponsor
Anna Huguenard
View Trial →
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05533697 Phase 1, Phase 2
Recruiting
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint ...
Condition
Advanced Solid Tumors
Enrollment
361 pts
Location
United States, Australia, Spain
Sponsor
ModernaTX, Inc.
View Trial →
Page 1 of 12 — 296 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology